Cargando…

Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress

BACKGROUND: The innate immune response is the first line of defence against invading microorganisms and it is also activated in different neurologic/neurodegenerative pathological scenarios. As a result, the family of the innate immune toll-like receptors (TLRs) and, in particular, the genetic/pharm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gárate, Iciar, García-Bueno, Borja, Madrigal, José Luis Muñoz, Caso, Javier R, Alou, Luis, Gómez-Lus, María Luisa, Leza, Juan Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897306/ https://www.ncbi.nlm.nih.gov/pubmed/24410883 http://dx.doi.org/10.1186/1742-2094-11-8

Ejemplares similares

Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression
por: Gárate, Iciar, et al.
Publicado: (2011)

Intracellular inflammatory and antioxidant pathways in postmortem frontal cortex of subjects with major depression: effect of antidepressants
por: Martín-Hernández, David, et al.
Publicado: (2018)

Paliperidone Prevents Brain Toll-Like Receptor 4 Pathway Activation and Neuroinflammation in Rat Models of Acute and Chronic Restraint Stress
por: MacDowell, KS, et al.
Publicado: (2015)

Selective inhibition of Toll-like receptor 4 signaling by the small molecule TAK-242
por: Kawamoto, T, et al.
Publicado: (2006)

The Toll-like receptor 4 antagonist TAK-242 protects against chronic pancreatitis in rats
por: Pan, Long-Fei, et al.
Publicado: (2017)

CCL2 Inhibition of Pro-Resolving Mediators Potentiates Neuroinflammation in Astrocytes
por: Gutiérrez, Irene L., et al.
Publicado: (2022)

TAK-242, a Toll-Like Receptor 4 Antagonist, Protects against Aldosterone-Induced Cardiac and Renal Injury
por: Zhang, Yide, et al.
Publicado: (2015)

TAK-242, an antagonist for Toll-like receptor 4, protects against acute cerebral ischemia/reperfusion injury in mice
por: Hua, Fang, et al.
Publicado: (2015)

Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis
por: Bhattacharyya, Swati, et al.
Publicado: (2018)

TAK-242, a toll-like receptor 4 antagonist, against brain injury by alleviates autophagy and inflammation in rats
por: Feng, Yan, et al.
Publicado: (2023)

Investigation of toll-like receptor (TLR) 4 inhibitor TAK-242 as a new potential anti-rheumatoid arthritis drug
por: Samarpita, Snigdha, et al.
Publicado: (2020)

TAK-242 Ameliorates Hepatic Fibrosis by Regulating the Liver-Gut Axis
por: Liu, Sujie, et al.
Publicado: (2022)

Toll-like receptor 4 agonist and antagonist lipopolysaccharides modify innate immune response in rat brain circumventricular organs
por: Vargas-Caraveo, Alejandra, et al.
Publicado: (2020)

Chronic immobilisation stress ameliorates clinical score and neuroinflammation in a MOG-induced EAE in Dark Agouti rats: mechanisms implicated
por: Pérez-Nievas, Beatriz G, et al.
Publicado: (2010)

TAK-242, a specific inhibitor of Toll-like receptor 4 signalling, prevents endotoxemia-induced skeletal muscle wasting in mice
por: Ono, Yuko, et al.
Publicado: (2020)

Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model
por: Fellner, Avi, et al.
Publicado: (2017)

TAK-242 ameliorates contact dermatitis exacerbated by IL-36 receptor antagonist deficiency
por: Fukushima, Hidehiko, et al.
Publicado: (2020)

TAK242 suppresses the TLR4 signaling pathway and ameliorates DCD liver IRI in rats
por: Zhong, Xiang, et al.
Publicado: (2019)

TLR4 inhibitor TAK-242 attenuates the adverse neural effects of diet-induced obesity
por: Moser, V. Alexandra, et al.
Publicado: (2018)

Dual effects of noradrenaline on astroglial production of chemokines and pro-inflammatory mediators
por: Hinojosa, Ara E, et al.
Publicado: (2013)

TAK-242, a novel Toll-like receptor 4 signal transduction inhibitor, protects mice in Escherichia coli-induced and lipoteichoic acid-induced lethality models
por: Ii, M, et al.
Publicado: (2006)

TAK-242, a small-molecule inhibitor of Toll-like receptor 4 signalling, unveils similarities and differences in lipopolysaccharide- and lipidinduced inflammation and insulin resistance in muscle cells
por: Hussey, Sophie E., et al.
Publicado: (2012)

Targeting Toll-like receptor 4 with CLI-095 (TAK-242) enhances the antimetastatic effect of the estrogen receptor antagonist fulvestrant on non-small cell lung cancer
por: Fan, S., et al.
Publicado: (2020)

Systemic Administration of Oleoylethanolamide Protects from Neuroinflammation and Anhedonia Induced by LPS in Rats
por: Sayd, Aline, et al.
Publicado: (2015)

Prenatal exposure to TAK242 affects the childhood autism in offspring in animal models of autism spectrum disorder
por: Xu, Xiaoyan, et al.
Publicado: (2017)

TAK-242 ameliorates epileptic symptoms in mice by inhibiting the TLR4/NF-κB signaling pathway
por: Dong, Jibo, et al.
Publicado: (2022)

Sulfonamide Prodrugs with a Two-Stage Release Mechanism for the Efficient Delivery of the TLR4 Antagonist TAK-242
por: Kostyo, Jessica H., et al.
Publicado: (2022)

Inhibition of intimal hyperplasia in murine aortic allografts by administration of a small-molecule TLR4 inhibitor TAK-242
por: Wu, Chuangyan, et al.
Publicado: (2017)

TAK-242 ameliorates DSS-induced colitis by regulating the gut microbiota and the JAK2/STAT3 signaling pathway
por: Wang, Jiajia, et al.
Publicado: (2020)

Alternative Method to Detect Neuronal Degeneration and Amyloid β Accumulation in Free-Floating Brain Sections With Fluoro-Jade
por: Gutiérrez, Irene L., et al.
Publicado: (2018)

Expression of the Genetic Suppressor Element 24.2 (GSE24.2) Decreases DNA Damage and Oxidative Stress in X-Linked Dyskeratosis Congenita Cells
por: Manguan-Garcia, Cristina, et al.
Publicado: (2014)

CCL2/MCP-1 modulation of microglial activation and proliferation
por: Hinojosa, Ara E, et al.
Publicado: (2011)

Lipopolysaccharide enters the rat brain by a lipoprotein-mediated transport mechanism in physiological conditions
por: Vargas-Caraveo, Alejandra, et al.
Publicado: (2017)

Noradrenaline in Alzheimer’s Disease: A New Potential Therapeutic Target
por: Gutiérrez, Irene L., et al.
Publicado: (2022)

Do face masks increase the rate of the Staphylococcus aureus nasal carriers?
por: Urquía-Cutillas, Salvador, et al.
Publicado: (2023)

Disinhibition-Like Behavior Correlates with Frontal Cortex Damage in an Animal Model of Chronic Alcohol Consumption and Thiamine Deficiency
por: Moya, Marta, et al.
Publicado: (2022)

TAK-242 protects against oxygen-glucose deprivation and reoxygenation-induced injury in brain microvascular endothelial cells and alters the expression pattern of lncRNAs
por: Kong, Li-Yun, et al.
Publicado: (2023)

Immune System and Brain/Intestinal Barrier Functions in Psychiatric Diseases: Is Sphingosine-1-Phosphate at the Helm?
por: Martín-Hernández, David, et al.
Publicado: (2023)

Aberrantly activated TAK1 links neuroinflammation and neuronal loss in Alzheimer's disease mouse models
por: Sai, Kazuhito, et al.
Publicado: (2023)

A high-fat diet decreases GABA concentration in the frontal cortex and hippocampus of rats
por: Sandoval-Salazar, Cuauhtemoc, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8lj2oat22ajlh6got4ebald8ia